Actively Recruiting
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
Led by University of California, San Francisco · Updated on 2025-10-09
36
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
T
Tobacco Related Disease Research Program
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to design and test the first mobile contingency management (CM) smoking cessation intervention for military Veterans undergoing major elective surgery. Smoking is the leading risk factor for postoperative complications and is associated with longer hospital stays, reoperations, and 30-day mortality. Smoking rates among patients undergoing major elective surgery are high, 22.3-43.0%. It is imperative to identify efficacious, strategically timed smoking cessation interventions for surgery patients. CM incentivizes smoking cessation through positive reinforcement (rewards) when bioverified abstinence is achieved. To ensure feasibility, CM must be tailored to the clinical context. CM for smoking cessation has never been delivered before and after major surgery, nor has mobile CM bioverification been trialed perioperatively. The investigators will develop and test a tailored mobile smoking cessation CM protocol for Veterans undergoing major elective surgery.
CONDITIONS
Official Title
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English-speaking
- Veteran enrolled in healthcare at San Francisco VA Health Care System
- Veteran scheduled for major elective surgery within the next 6 months, including general, spinal, thoracic, vascular, urological, gynecological, orthopedic, or gender-affirming surgeries
- Current cigarette smoking of at least 1 cigarette per day on average in the past 30 days
- Willingness to receive smoking cessation interventions
You will not qualify if you...
- Psychotic disorders, bipolar disorder, neurocognitive disorder, or other unstable psychiatric or medical conditions as judged by the study team
- Untreated active problem gambling with a severity index score of 8 or higher
- Enrollment in end-of-life or palliative care
- Surgery planned for clinical indication of cancer
- Inability to meet study time commitments
- Currently pregnant or planning pregnancy during the study for people of childbearing potential aged 18 to 55
- Suicide attempt or suicidal thoughts with intent within 30 days before enrollment
- Participation in another tobacco cessation trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
San Francisco VA Health Care System
San Francisco, California, United States, 94121
Actively Recruiting
Research Team
E
Ellen Herbst, MD
CONTACT
Y
Yim Fan (Christy) Wong, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here